Validation of New Type Radiopaque Marker in The Evaluation of Colonic Transit Time

NCT06850415 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-09-30

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if the local made colonic transit capsule can be use to diagnose slow transit constipation. The main questions it aims to answer are:

* Does the local made colonic transit capsule correlate with the standard colonic capsule in the diagnosis of slow transit constipation?
* Does the number of remained radiopaque marker similar between the two test after five days of ingestion?

Researchers will compare the local made colonic capsule with the standard Sitzmark colonic capsule to see the correlation.

Participants will:

* Take both local made colonic capsule and Sitzmark colonic capsule at the same time.
* Obtain abdominal x-ray 5 days after capsule ingestion.
* Keep a diary of their symptoms and medication used during investigation.

Conditions

  • Slow Transit Constipation
  • Colonic Transit
  • Chronic Constipation
  • Colonic Transit Capsule
  • Radiopaque Marker

Interventions

DEVICE

Siriraj gastrointestinal transit capsule

The Siriraj gastrointestinal transit capsule is a local made colonic transit capsule. Each capsule contains 6 circular-shaped radiopaque markers.

DEVICE

Sitz-Markers

The standard Sitzmark colonic capsule containing 24 ring-shaped radiopaque markers.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-03-30
Primary Completion
2025-05-30
Completion
2025-05-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06850415 on ClinicalTrials.gov